Tag: Rigel Pharmaceuticals

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -13.10% this year. Over the last six months, there has been a weaker performance of 18.87%. The price of RIGL leaped by -17.65% during the last 30 days period. For the last 5-days stocks have slided -5.97%. Rigel Pharmaceuticals’s stock has had a calm market performance. The 1-year high for the company’s stock was $1.96 on 05/18/23, and the lowest price during the same period was

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Rigel Pharmaceuticals’s current trading price is -31.63% away from its 52-week high, while its distance from the 52-week low is 88.20%. The stock’s price range for this period has been between $0.71 and $1.96 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.72 million for the day, a number notably higher than the average daily volume of 1.1 million over the last three months. Rigel Pharmaceuticals experienced a somewhat shaky performance in

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Rigel Pharmaceuticals’s current trading price is -18.37% away from its 52-week high, while its distance from the 52-week low is 124.71%. The stock’s price range for this time frame has been between $0.71 and $1.96. The trading volume of the company’s shares in the Healthcare reached around 0.76 million for the day, which was evidently lower than the average daily volume of 0.95 million over the last three months. Rigel Pharmaceuticals’s stock has had a calm market performance. The